ZTS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Zoetis Inc. (ZTS) Investors with Lo... Newsfile Corp
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on ZTS
    Zoetis to Participate in the Barclays Global Healthcare Conference
    8:30a ET March 5 '24 BusinessWire

    Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:30 a.m. ET.

    Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

    About Zoetis

    As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide - from veterinarians and pet owners to livestock farmers and ranchers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.

    ZTS-COR ZTS-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240304739185/en/

    SOURCE: Zoetis Inc.

    <img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240304739185r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />

    Media Contacts:
    Jenielle Alonso
    1-973-945-4333 (o)
    jenielle.alonso@zoetis.com 
    
    Laura Panza
    1-973-975-5176 (o)
    laura.panza@zoetis.com
    
    
    Investor Contacts:
    Steve Frank
    1-973-822-7141 (o)
    steve.frank@zoetis.com 
    
    Nick Soonthornchai
    1-973-443-2792 (o)
    nick.soonthornchai@zoetis.com
    

    COMTEX_448765617/1006/2024-03-05T08:30:07

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf o...
    4:10p ET May 2 '24 GlobeNewswire
    Zoetis Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman, LLC E...
    11:02a ET May 2 '24 ACCESSWIRE
    ZTS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourag...
    9:47a ET May 2 '24 ACCESSWIRE
    Zoetis Announces First Quarter 2024 Results
    7:00a ET May 2 '24 BusinessWire
    Zoetis Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman, LLC E...
    11:01a ET May 1 '24 ACCESSWIRE
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigatin...
    10:03p ET April 30 '24 ACCESSWIRE
    ZTS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourage...
    4:56p ET April 30 '24 Newsfile Corp
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf o...
    4:02p ET April 30 '24 Newsfile Corp
    Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impact...
    2:52p ET April 30 '24 GlobeNewswire
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to ...
    12:40p ET April 30 '24 GlobeNewswire

    Market data provided by News provided by